Results
3
3 companies
AFT Pharmaceuticals
Market Cap: NZ$270.6m
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.59
7D
-0.4%
1Y
-17.3%
BLIS Technologies
Market Cap: NZ$17.9m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.014
7D
0%
1Y
-12.5%
Rua Bioscience
Market Cap: NZ$5.9m
Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.027
7D
3.8%
1Y
-62.0%